Introduced
by
To allow pharmacists to dispense FDA-designated interchangeable biological drug products.
Referred to the Committee on Health Policy
Reported without amendment
With the recommendation that the substitute (H-2) be adopted and that the bill then pass.
Passed in the House 101 to 5 (details)
Referred to the Committee on Health Policy
Reported without amendment
With the recommendation that the substitute (S-1) be adopted and that the bill then pass.